United Kingdom· GB-APID-4650111000001108
Metvix 16% cream
A methyl aminolevulinate product containing methyl aminolevulinate, registered in United Kingdom by Galderma (UK) Ltd. The same ATC class is registered in 13 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Methyl aminolevulinate is registered in 13 of 19 countries.
Countries holding a registration under ATC L01XD03 (methyl aminolevulinate), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 7 of them publish a price we can compare per daily dose
Methyl aminolevulinate · ATC L01XD03
13 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Methyl aminolevulinate
- Manufacturer
- Galderma (UK) Ltd
- Country
- United Kingdom (GB)
- ATC code
- L01XD03
- ATC class
- Methyl aminolevulinate
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin5020465200000
- gtin05020465200000
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Methyl aminolevulinate in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandLuxeraGalderma Nordic AB
- SwedenLuxera 160 mg/g KrämGalderma Nordic AB
- GermanyLuxermGalderma Laboratorium Gmbh
- United StatesKRX Aesthetics PD-13 TherapyBY KIN AESTHETICS LLC
- IrelandMetvix 160 mg/g creamGalderma International
- IcelandMetvixGalderma Nordic AB*
- NorwayMetvixGalderma Nordic AB
- FranceMETVIXIA 168 mg/g, crèmeGALDERMA INTERNATIONAL
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Austria · Luxerm, Metvix
- Belgium · Metvix
- Germany · Luxerm, Metvix
- Denmark · Metvix
- Spain · Metvix
- Finland · Metvix
- France · Metvixia
- Greece · Metvix
- Ireland · Metvix
- Iceland · Metvix
- Italy · Metvix
- Luxembourg · Metvix
- Malta · Metvix
- Netherlands · Metvix
- Norway · Metvix
- Portugal · Metvix
- Sweden · Luxera, Metvix
- Slovakia · Metvix
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cf6e7668-5778-4285-811a-f106bd3ef566 GET /v1/drugs/cf6e7668-5778-4285-811a-f106bd3ef566?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "4650111000001108",
"desc": "Metvix 16% cream (Galderma (UK) Ltd)",
"form": "Cutaneous cream",
"vpid": "41902811000001100",
"source": "dmd",
"vtm_id": "13296801000001109",
"strength": "160 mg",
"substance": "Methyl aminolevulinate",
"ingredient": "Methyl aminolevulinate hydrochloride",
"supplier_code": "138401000001109"
}See everything about methyl aminolevulinate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.